Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors

Guidance documents for management of drugs for clinical trials involving human subjects. The sponsor must ensure that the clinical trial is conducted in accordance with the requirements of the protocol, which has been authorized by Health Canada and approved by REB(s).

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2020-04-07

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data